Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lise Hobolth

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2013
Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised studyLise Hobolth, Flemming Bendtsen, Erik F Hansen, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2011
Effects of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosisChristine Winkler, Lise Hobolth, Aleksander Krag, et al.
Gut|April 21, 2011
Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosisSøren Møller, Lise Hobolth, Christine Winkler, et al.
Scandinavian Journal of Gastroenterology|February 8, 2018
Prognosis of patients with ascites after PleurX insertion: an observational studyAgnete Nordheim Riedel, Nina Kimer, Lise Hobolth, et al.
Frontiers in Medicine|October 11, 2021
Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based StudyThit Mynster Kronborg, Henriette Ytting, Lise Hobolth, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Diagnosis of Portal HypertensionSøren Møller, Karen V Danielsen, Lise Hobolth, et al.
Hepatology Communications|October 14, 2025
The pathophysiological role of portal hypertension in metabolic dysfunction-associated steatotic liver diseaseSøren Møller, Sannia M S Sjöstedt, Lise Hobolth, et al.
Plos One|August 30, 2019
Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosisEmilie Garnæs, Christian Mortensen, Lise Hobolth, et al.
Ugeskrift for Laeger|April 15, 2020
[Outpatient control and rehabilitation in decompensated liver cirrhosis should be an interdisciplinary approach]Malene Barfod O'Connell, Lise Hobolth, Ane Søgaard Teisner, et al.
Scandinavian Journal of Gastroenterology|March 10, 2012
Carvedilol or propranolol in portal hypertension? A randomized comparisonLise Hobolth, Søren Møller, Henning Grønbæk, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2013
Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised studyLise Hobolth, Flemming Bendtsen, Erik F Hansen, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2011
Effects of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosisChristine Winkler, Lise Hobolth, Aleksander Krag, et al.
Gut|April 21, 2011
Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosisSøren Møller, Lise Hobolth, Christine Winkler, et al.
Scandinavian Journal of Gastroenterology|February 8, 2018
Prognosis of patients with ascites after PleurX insertion: an observational studyAgnete Nordheim Riedel, Nina Kimer, Lise Hobolth, et al.
Frontiers in Medicine|October 11, 2021
Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based StudyThit Mynster Kronborg, Henriette Ytting, Lise Hobolth, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Diagnosis of Portal HypertensionSøren Møller, Karen V Danielsen, Lise Hobolth, et al.
Hepatology Communications|October 14, 2025
The pathophysiological role of portal hypertension in metabolic dysfunction-associated steatotic liver diseaseSøren Møller, Sannia M S Sjöstedt, Lise Hobolth, et al.
Plos One|August 30, 2019
Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosisEmilie Garnæs, Christian Mortensen, Lise Hobolth, et al.
Ugeskrift for Laeger|April 15, 2020
[Outpatient control and rehabilitation in decompensated liver cirrhosis should be an interdisciplinary approach]Malene Barfod O'Connell, Lise Hobolth, Ane Søgaard Teisner, et al.
Scandinavian Journal of Gastroenterology|March 10, 2012
Carvedilol or propranolol in portal hypertension? A randomized comparisonLise Hobolth, Søren Møller, Henning Grønbæk, et al.
Pageof 4